Market Outlook


  • Tuesday Market Roadmap  Tuesday, 8 Jan 2013 | 9:00 AM ET

    The "Squawk on the Street" news team reports on today's market moving stories; including Yum! Brands' China battle; Sears' executive shuffle; and Target's plan to match online prices.

  • Stock Picking Tips For 2013  Tuesday, 8 Jan 2013 | 8:42 AM ET

    John Rogers, Ariel Investments chairman, CEO & CIO, reveals his top stock bets and explains why a "slow and steady" strategy works best in an uncertain political environment.

  • Is the Fed Acting on 'Cross Purposes?'  Tuesday, 8 Jan 2013 | 8:31 AM ET

    A check on mortgage rates and Fed policy, with CNBC's Rick Santelli and Steve Liesman; Sen. Ron Johnson, (R-WI); and John Allison, Cato president.

  • JPMorgan's Staley Joins BlueMountain Tuesday, 8 Jan 2013 | 8:12 AM ET
    James E. Staley

    Former JPMorgan investment-banking chief James "Jes" Staley is joining BlueMountain Capital, the $12 billion hedge fund.

  • Investors: Time to Get Your Risk On?  Tuesday, 8 Jan 2013 | 8:03 AM ET

    John Silvia, Wells Fargo Securities; and Ed Keon, Quantitative Management Associates, provide a read on market moves for 2013.

  • High Yield Bonds Have Run Their Course: Pro  Tuesday, 8 Jan 2013 | 7:43 AM ET

    Thomas Strauss, Cowen Group vice chairman, explains why he believes fixed income prices are high, and it's time for investors to consider moving into equities.

  • What Worries Small Biz Owners Most  Tuesday, 8 Jan 2013 | 7:33 AM ET

    How is small business feeling about the state of the economy? CNBC's Steve Liesman, and Bill Dunkelberg, National Federation of Independent Business, break down the results from the latest NFIB Survey.

  • Business Bumps Against Debt Ceiling  Tuesday, 8 Jan 2013 | 7:15 AM ET

    Sen. Ron Johnson, (R-WI); and John Allison, Cato president, explain how fiscal uncertainty is impacting the business environment.

  • Why 'Dr. Doom' Is Now 'Deeply Uncomfortable'  Tuesday, 8 Jan 2013 | 7:05 AM ET

    Marc Faber, "The Gloom Boom & Doom Report," explains why he owns gold and would look at Vietnam, China and Japan for investment opportunities this year.

  • Trader Buzz Before the Bell  Tuesday, 8 Jan 2013 | 6:41 AM ET

    A look at what traders will be watching ahead of the opening bell, with Kevin Ferry, Cronus Futures Management.

  • Cast a Wider Net: Pro  Tuesday, 8 Jan 2013 | 6:33 AM ET

    Time to rethink global equities? Russ Koesterich, BlackRock chief investment strategist, discusses where investors are likely to find opportunities in the year ahead.

  • $1 Trillion Platinum Coin?  Tuesday, 8 Jan 2013 | 6:20 AM ET

    Drew Matus, UBS senior U.S. economist, explains why the Fed would not monetize a platinum coin, and provides an outlook on the markets for 2013.

  • AIG: Thank You America, Now Pay Up  Tuesday, 8 Jan 2013 | 6:00 AM ET

    CNBC's Kelly Evans tells you what the markets will be watching as we approach the start of trading in the U.S.

  • Oops! Earnings Season Brings Plenty of Excuses Monday, 7 Jan 2013 | 7:11 PM ET

    Earnings season unofficially kicks off Tuesday. From Sandy to the "fiscal cliff" get ready to here every excuse in the book for weak profits and revenue!

  • Wall St. Without Washington Worry?  Monday, 7 Jan 2013 | 7:10 PM ET

    The Dow Jones average and the S&P 500 dropped slightly in today's trading, with Jonathan Golub, UBS chief U.S. equity strategist.

  • A Return to Equities in 2013: Deutsche Bank  Monday, 7 Jan 2013 | 7:10 PM ET

    Ajay Kapur, Head of Equity Strategy, Asia, Deutsche Bank thinks 2013 will be a good year for equities. He expects 10-15% upside for Asian markets and 10% growth in EPS.

  • No Huddle Offense: Earnings Season Ahead  Monday, 7 Jan 2013 | 6:58 PM ET

    Mad Money host Jim Cramer shares his final thoughts of the day.

  • Exact Sciences' CEO Kevin Conroy weighs in on the Medicare spending talks in Washington, and discusses his company's development of non-invasive ways to detect colorectal cancer.

  • Cramer's Top Performers Playoff  Monday, 7 Jan 2013 | 6:25 PM ET

    Mad Money host Jim Cramer begins the annual stock Super Bowl by pitting the best performers in the Dow Jones average against each other.

  • NPS Pharmaceuticals CEO on Gattex's FDA Approval  Monday, 7 Jan 2013 | 6:15 PM ET

    NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.